Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Research & Development (2014 - 2026)

Updated

Skye Bioscience (SKYE) reported Research & Development of $3.94 million for Q2 2026, down 72.5% from $14.34 million a year earlier and down 50.3% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Research & Development (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Skye Bioscience's Research & Development came in at $32.7 million, down 4.4% year-over-year; for FY2025, it came in at $42.36 million, up 126.5% from FY2024.

  • Research & Development has a five-year compound annual growth rate of 85.2% (FY2020 to FY2025).
  • By year, Research & Development came in at $18.7 million in FY2024 (+221.4%), $5.82 million in FY2023 (-3.2%), $6.01 million in FY2022 (+105.1%) and $2.93 million in FY2021 (+50.8%).
  • The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q1 2024.
  • Year over year, Research & Development gained in seven of the last eight quarters, with growth averaging 159.6%.
  • The high point for year-over-year Research & Development in five years was Q3 2022 (growth of 443.7%); the low point was Q2 2026 (a decline of 72.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $7.94 million (Q1 2026), $11.47 million (Q4 2025) and $9.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 4.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 2.57 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.89 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.02 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn - 1.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.32 Mn
Jun 30, 2026 3.94 Mn
Mar 31, 2026 7.94 Mn
Dec 31, 2025 11.47 Mn
Sep 30, 2025 9.36 Mn
Jun 30, 2025 14.34 Mn
Mar 31, 2025 7.20 Mn
Dec 31, 2024 7.79 Mn
Sep 30, 2024 4.88 Mn
Jun 30, 2024 4.08 Mn
Mar 31, 2024 1.95 Mn
Dec 31, 2023 1.59 Mn
Sep 30, 2023 1.25 Mn
Jun 30, 2023 1.79 Mn
Mar 31, 2023 1.18 Mn
Dec 31, 2022 1.54 Mn
Sep 30, 2022 1.78 Mn
Jun 30, 2022 1.43 Mn
Mar 31, 2022 1.27 Mn
Dec 31, 2021 1.11 Mn
API Access

Skye Bioscience Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=SKYE&period=max&api_key=YOUR_API_KEY